 |
The following information is NOT intended to endorse drugs or recommend therapy. While these reviews might be helpful, they are not a substitute for the expertise, skill, knowledge and judgement of healthcare practitioners in patient care.
Learn more about Mutamycin.
No reviews have yet been submitted. Be the first to review this drug.
Data Support Ongoing Phase 2 Study in Metastatic Bladder Cancer BOTHELL, Wash. and VANCOUVER, British Columbia, Feb. 2, 2012 /PRNewswire/ -- OncoGenex...
A new Swiss-American study indicates that long-term use of the popular diabetes medication metformin may lower the risk of developing pancreatic cancer, at...
– Infinity Stops Phase 2 Study Following Preliminary Analysis Showing Trial Would Not Meet Primary Endpoint of Overall Survival – – No Unexpected...
– Infinity to Review Saridegib Development Program on January 31, 2012, in New York City – CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jan 20, 2012 -...
A new blood test may hold promise as a means of early detection and diagnosis for often deadly pancreatic cancers. Reporting Tuesday at the annual...
Looking for answers? Ask a question or go join the Mutamycin support group to connect with others who have similar interests.
Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines & natural products. This material is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Data sources include Micromedex™ (updated Jan 27th, 2011), Cerner Multum™ (updated Jan 3rd, 2012), Wolters Kluwer™ (updated Jan 31st, 2012) and others.
To view content sources and attributions, refer to our editorial policy.
Copyright © 2000-2012 Drugs.com. All rights reserved.
We comply with the HONcode standard for trustworthy health information.
Verify here
